Immucell (ICCC) Cash from Investing Activities Growth (3y) (2013 - 2025)
Powered by 
Analysis
Immucell (ICCC) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 2.46% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -55.36% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -36.76% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -16.96% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 51.76% |
| Sep 30, 2025 | 6.93% |
| Jun 30, 2025 | 48.89% |
| Mar 31, 2025 | 25.52% |
| Dec 31, 2024 | 34.66% |
| Sep 30, 2024 | 49.12% |
| Jun 30, 2024 | 50.56% |
| Mar 31, 2024 | -28.20% |
| Dec 31, 2023 | -64.52% |
| Sep 30, 2023 | 28.73% |
| Jun 30, 2023 | 34.89% |
| Mar 31, 2023 | -43.52% |
| Dec 31, 2022 | -33.04% |
| Sep 30, 2022 | -36.58% |
| Jun 30, 2022 | 52.39% |
| Mar 31, 2022 | -57.64% |
| Dec 31, 2021 | -92.40% |
| Sep 30, 2021 | -204.19% |
| Jun 30, 2021 | -20.55% |
| Mar 31, 2021 | 36.42% |